SureTrader
Cannabis Stocks News
Interactive Brokers Advertisement
Home > Boards > US Listed > Biotechs > Advaxis, Inc. (ADXS)

ADXS Board of Directors, please consider putting the

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (7) | Next 10 | Previous | Next
fbg0316 Member Profile
 
Followed By 6
Posts 2,469
Boards Moderated 0
Alias Born 12/14/09
160x600 placeholder
Current Report Filing (8-k) "Edgar (US Regulatory)" - 9/25/2017 4:55:48 PM
Biotech's Recently Under the Microscope, Analyst Coverage "InvestorsHub NewsWire" - 9/20/2017 8:00:00 AM
Advaxis to Present at Cantor Fitzgerald Global Healthcare Conference "Business Wire" - 9/18/2017 9:02:00 AM
Quarterly Report (10-q) "Edgar (US Regulatory)" - 9/11/2017 4:34:01 PM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 9/11/2017 4:07:05 PM
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 9/5/2017 4:31:58 PM
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 9/5/2017 4:31:58 PM
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 8/1/2017 4:33:09 PM
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 8/1/2017 4:32:40 PM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 7/21/2017 5:02:24 PM
Initial Statement of Beneficial Ownership (3) "Edgar (US Regulatory)" - 7/12/2017 5:31:49 PM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 7/7/2017 6:04:08 AM
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 7/3/2017 4:33:21 PM
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 7/3/2017 4:32:55 PM
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 7/3/2017 4:32:24 PM
Advaxis’ Axalimogene Filolisbac Data Selected for Poster Presentation at ESGO 2017 "Business Wire" - 6/26/2017 8:55:00 AM
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 6/20/2017 6:32:13 PM
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 6/20/2017 6:31:48 PM
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 6/20/2017 6:31:48 PM
Advaxis to Present at 2017 BIO International Convention "Business Wire" - 6/16/2017 8:00:00 AM
Advaxis to Be Featured on Worldwide Business with kathy ireland® "Business Wire" - 6/14/2017 8:00:00 AM
Advaxis Details Registrational Trials, EU Regulatory and Commercial Plans at Annual Investor & Analyst Day "Business Wire" - 6/13/2017 12:30:00 PM
Advaxis to Webcast Investor & Analyst Day 2017 "Business Wire" - 6/9/2017 8:00:00 AM
Webcast of Advaxis Presentation at Jefferies 2017 Global Healthcare Conference Now Available "Business Wire" - 6/8/2017 9:17:00 AM
Advaxis to Present at Jefferies 2017 Global Healthcare Conference "Business Wire" - 6/7/2017 8:30:00 AM
fbg0316   Tuesday, 08/22/17 10:26:25 AM
Re: None
Post # of 35838 
ADXS Board of Directors, please consider putting the company on the auction block and selling for $20 to $25 ($800 million to $1 billion valuation). Arguably, this would be in the best interest of 1) patients (getting the constructs to market faster with trial execution done by the expertise of a larger pharma or biotech) and 2) ADXS investors (who are down 50% from the recapitalization price of $12 over the last four years). Why risk putting into place another CEO who turns out to fumble in advancing the platform (Moore) or one who turns out to be unethical and puts his personal financial interests above shareholder interests (O'Connor). In the latest corporate presentation, you cite around $1 billion of potential future deal value based on current collaborations - you should be able to sell the entire company for approximately this value ($20 to $25 share price). Do what's right for the company, its patients and investors.

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (7) | Next 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist